drugset / Trial / NCT07712783

Lateral QL Block vs Intrathecal Morphine for Cesarean Section

NCT07712783

Not yet recruiting 56 enrolled Ondokuz Mayıs University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Effective postoperative analgesia after cesarean delivery is essential for maternal recovery, early mobilization, breastfeeding, and maternal-infant bonding. Although intrathecal morphine (ITM) is considered the gold standard for post-cesarean analgesia, its use is associated with opioid-related adverse effects. Ultrasound-guided lateral quadratus lumborum block (QLB-I) has emerged as a promising alternative. This randomized, double-blind, non-inferiority trial aims to compare the postoperative analgesic efficacy of lateral QLB-I with ITM. Secondary outcomes include postoperative opioid consumption, pain scores, opioid-related adverse effects, quality of recovery (ObsQoR-11T), and maternal satisfaction.

Timeline

Start
2026-07-15
Primary completion
2026-09-01
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Background Morphine Other / unclassified 0.01 mg/kg Intravenous
Background Morphine Other / unclassified 0.015 mg/kg Intravenous

Indications

No indication recorded.